Novaferon

BIOLOGICAL4 trials

Sponsors

The Affiliated Hospital of the Chinese Academy of Military Medical Sciences, Genova Inc.

Conditions

Covid19Metastatic Colorectal Cancer

Phase 2

Recombinant Anti-tumor and Anti-virus Protein for Injection Plus Xeloda in Treatment of Metastatic Colorectal Cancer

The Affiliated Hospital of the Chinese Academy of Military Medical SciencesMetastatic Colorectal Cancer

Start: 2014-02-28End: 2016-12-31Target: 30Updated: 2016-01-05

Phase 3

Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19

Genova Inc.Covid19

Start: 2021-06-10End: 2022-08-31Target: 914Updated: 2022-06-03

Novaferon for COVID-19 Treatment Trial (NCTT-005)

Genova Inc.Covid19

Start: 2021-03-25End: 2023-04-30Target: 385Updated: 2022-01-28

Novaferon in Non-hospitalized Adult Patients With Mild COVID-19

Genova Inc.Covid19

Start: 2021-10-28End: 2022-06-30Target: 222Updated: 2022-03-03